FDA Adverse Event Injury Summary report: N

OVATION IX

MDR report key: 13529897 · Received February 14, 2022

Report

Report Number
3008011247-2022-00010
Event Type
Injury
Date Received
February 14, 2022
Date of Event
January 24, 2022
Report Date
January 24, 2022
Manufacturer
ENDOLOGIX SANTA ROSA
Product Code
MIH
UDI-DI
M701TVAB3480J1
PMA / PMN Number
P120006
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE INVOLVED IN THIS EVENT WILL NOT BE RETURNED FOR EVALUATION AS IT REMAINS IMPLANTED IN THE PATIENT. PATIENT MEDICAL RECORDS AND IMAGING STUDIES WILL BE REQUESTED FOR FURTHER EVALUATION BY THE CLINICAL SPECIALIST. IF ADDITIONAL INFORMATION PERTINENT TO THE INCIDENT IS OBTAINED, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

THE REPORTED ADVERSE EVENT/INCIDENT WAS INVESTIGATED IN ALIGNMENT WITH ENDOLOGIX OPERATING PROCEDURES AND WORK INSTRUCTIONS. WHERE POSSIBLE, IT IS ENDOLOGIX PRACTICE TO MAKE AT LEAST THREE GOOD FAITH EFFORTS TO RETRIEVE A REPORTED ADVERSE EVENT/INCIDENT RELATED DEVICE AS WELL AS MEDICAL RECORDS AND MEDICAL IMAGING. AN EVALUATION OF THE MANUFACTURING RECORD WAS COMPLETED. A REVIEW OF THE PART NUMBER/LOT NUMBER COMBINATION NEEDED FOR DEVICE IDENTIFICATION SHOWS THE DEVICE TO HAVE BEEN PROPERLY MANUFACTURED AND RELEASED IN ACCORDANCE WITH THE DEVICE MASTER RECORD. THE REVIEW CONFIRMS THERE WERE NO MANUFACTURING OR PROCESSING NON-CONFORMITIES IDENTIFIED THAT WOULD CONTRIBUTE TO THE REPORTED ADVERSE EVENT/INCIDENT. AN EVALUATION OF THE DEVICE COULD NOT BE COMPLETED. THE DEVICE WAS NOT RETURNED TO ENDOLOGIX FOR EVALUATION BECAUSE IT REMAINS IMPLANTED. A CLINICAL EVALUATION OF THE ADVERSE EVENT/INCIDENT WAS COMPLETED. AN EXAMINATION OF MEDICAL RECORDS AND/OR MEDICAL IMAGING RECEIVED BY ENDOLOGIX SHOWS THAT THE TYPE 1A ENDOLEAK, SAC GROWTH OF 35MM AND SECONDARY ENDOVASCULAR PROCEDURE ARE CONFIRMED. THE MIGRATION IS UNCONFIRMED. THIS IS MODERATELY CONSISTENT WITH THE REPORTED ADVERSE EVENT/INCIDENT. THE MOST LIKELY CAUSATION FOR THIS EVENT IS USER RELATED. THE RADIOPAQUE MARKERS WERE PLACED LOW (9.4MM BELOW THE RIGHT RENAL ARTERY). IT IS UNCLEAR IF THERE WAS MIGRATION OR IF THE AORTIC BODY HAD SUBOPTIMAL PLACEMENT AT THE INDEX PROCEDURE. THE PROCEDURE RELATED HARM IDENTIFIED WAS A POST OPERATIVE STROKE AND CEREBRAL ISCHEMIA. THE PATIENT HAD A CORONARY STENT PLACED 1 WEEK PRIOR TO THE REPAIR PROCEDURE (CAUTIONARY PRODUCT USE) AND HAD A HISTORY OF CORONARY ARTERY DISEASE (CAD). THE MRI STATED THE BRAIN EMBOLISM WAS MOST LIKELY A CARDIOMEGALY SOURCE. THE FINAL PATIENT STATUS WAS DISCHARGED HOME IN STABLE AND IMPROVING CONDITION ON THE FIFTH POST OPERATIVE DAY. NO ADDITIONAL INVESTIGATION OF THIS REPORTED ADVERSE EVENT/INCIDENT IS PLANNED. HOWEVER, SHOULD ADDITIONAL INFORMATION RELEVANT TO THE INVESTIGATION OUTCOME BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED. ENDOLOGIX WILL CONTINUE TO MONITOR THIS AND SIMILAR ADVERSE EVENTS/INCIDENTS.

Description of Event or Problem · 0

THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY FOUR (4) YEARS POST INITIAL PROCEDURE, DURING A ROUTINE FOLLOW UP, THERE WAS STENT GRAFT MIGRATION, A TYPE 1A ENDOLEAK AND ANEURYSM ENLARGEMENT NOTED. THE PHYSICIAN ELECTED TO RELINE THE ORIGINAL IMPLANTED DEVICES WITH AN ALTO STENT GRAFT SYSTEM TO RESOLVE THIS EVENT. THE PATIENT WAS REPORTED AS DOING WELL POST SECONDARY PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
559192 OVATION IX MAIN BODY MIH ENDOLOGIX SANTA ROSA TV-AB3480-J FS021717-17 M701TVAB3480J1

Patients

Seq Age Sex Outcome Treatment
1 73 YR Male Required Intervention OVATION IX ILIAC LIMB, LOT # FS061217-06| OVATION IX ILIAC LIMB, LOT # FS100616-19| OVATION PRIME FILL POLYMER, LOT # FF070617-01